Morgan Stanley’s second quarter results reflect the strength of its integrated business model amid favorable market conditions. The firm’s performance builds on prior quarters, with continued growth in equities trading, investment banking activity, and wealth management inflows. For investors, these figures provide insight into how the company is navigating a dynamic environment of client engagement, capital accretion, and operational efficiency across its Institutional Securities, Wealth Management, and Investment Management segments. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Morgan Stanley reported net revenues of $21.3 billion for the second quarter of 2026, compared with $16.8 billion a year earlier. Net income applicable to the firm reached $5.6 billion, or $3.46 per diluted share, versus $3.5 billion, or $2.13 per diluted share, in the prior-year period. The company achieved a return on tangible common equity (ROTCE) of 26.6%. Pre-tax income totaled $7.3 billion. These results exceeded consensus estimates, with EPS surpassing analyst projections of approximately $2.89 to $2.94. Wealth Management contributed significantly with record net new assets of $148 billion, while total client assets across Wealth and Investment Management reached $10 trillion. Institutional Securities posted record segment revenues of $11 billion.
Following the July 15, 2026 release, investor attention centered on the record top-line and bottom-line figures. The strong beat on earnings and revenue, combined with robust asset growth in Wealth Management, supported positive sentiment. Market participants noted the firm’s ability to deliver operating leverage through disciplined execution despite ongoing strategic investments. From what I see, the integrated model continues to provide a meaningful edge in capturing both institutional and retail flows.
When evaluating earnings like these, I often turn to Tickeron’s AI tools to scan for comparable patterns across the financial sector. One resource that stands out is the AI Screener, an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. In my view, this kind of capability adds useful context when reviewing results from a firm like Morgan Stanley (MS).
Investors will watch how the firm sustains momentum from its record first-half performance into the second half of the year. Key areas include continued client engagement in equities and investment banking, as well as the pace of net new asset inflows in Wealth Management. Management highlighted the benefits of the integrated firm model, which connects institutional and retail clients globally.
Cost discipline remains important, with technology-driven spending supporting infrastructure, AI-enabled efficiencies, and business growth. The year-to-date efficiency ratio of 65% provides a baseline for monitoring operating leverage.
Broader industry dynamics, such as market volatility, interest rate trends, and capital markets activity, will influence results. Capital accretion continues to offer flexibility for investments and shareholder returns. Upcoming catalysts include third-quarter developments and any updates on strategic initiatives across the firm’s segments. I’m watching this closely to see how the momentum carries forward.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The 10-day moving average for MS crossed bearishly below the 50-day moving average on August 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on August 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
MS moved below its 50-day moving average on August 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 354 cases, the price rose further within the following month. The odds of a continued upward trend are .
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 295 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.157) is normal, around the industry mean (4.401). P/E Ratio (17.302) is within average values for comparable stocks, (21.328). Projected Growth (PEG Ratio) (2.030) is also within normal values, averaging (1.691). Dividend Yield (0.019) settles around the average of (0.032) among similar stocks. P/S Ratio (4.634) is also within normal values, averaging (17.980).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers